🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Polish Multicenter PERTs PE Outcomes Registry

Recruitingn/aAges 18 Years - anyAllPoznan University of Medical Sciences
NCT04879069 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Pulmonary embolism (PE) is the third leading cause of cardiovascular mortality. The Pulmonary Embolism Response Team (PERT) concept offers a rapid and multidisciplinary approach focused on improving outcomes for patients with PE. All institutionalized PERTs in Poland have been invited to join the study. The goal of this registry is to describe current practice and outcomes in patients with acute PE treated by Polish PERTs.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. PE confirmed by computed tomography pulmonary angiography. 2. PE symptoms duration ≤ 14 days. 3. High-risk PE with hemodynamic instability (one of): * cardiac arrest * obstructive shock * persistent hypotension. 4. Intermediate-high risk PE patients with right ventricle dysfunction confirmed by imaging studies and elevated troponin level. Exclusion Criteria: 1\. Refusal to sign the informed consent form.
💊

What it tests

  • Not listed
📍

Where

1 site
Poznan University of Medical Sciences
Poznan, Poland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy